Navigation Links
Potential new drug for some patients with treatment-resistant lung cancer
Date:10/20/2013

BOSTON The investigational drug AZD9291, a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

Mutations in the growth factor gene EGFR are present in about 10 to 15 percent of patients with the most common form of lung cancer, non-small cell lung cancer (NSCLC). Most NSCLCs harboring these EGFR mutations, called activating mutations, respond to the EGFR inhibitor drugs erlotinib and gefitinib. A majority of such cancers, however, develop resistance to these drugs within about nine to 11 months. In many cases, this is due to the cancer cells acquiring a second mutation called EGFR T790M, also known as the "resistance mutation."

"There are no approved therapies to treat lung cancer patients who develop the second mutation in the EGFR that stops the currently available medicines from working," said Susan Galbraith, M.D., Ph.D., head of the Oncology Innovative Medicines Unit at AstraZeneca. "The innovative breakthrough was finding a series of molecules that could target both the activating and resistance mutant forms of EGFR more potently than normal EGFR, which led to development of the new EGFR kinase inhibitor, AZD9291.

"AZD9291 is highly active in preclinical models and is well tolerated in animal models. It inhibits both activating and resistant EGFR mutations while sparing the normal form of EGFR that is present in normal skin and gut cells, thereby reducing the side effects encountered with currently available medicines," she added.

The AstraZeneca scientists first showed that AZD9291 potently inhibited lung cancer cells with mutant EGFR, grown in lab dishes. They then tested the drug on mice bearing lung tumors with activating mutations and mice bea
'/>"/>

Contact: Lauren Riley
lauren.riley@aacr.org
215-446-7155
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study identifies potential treatment for lethal childhood leukemia
2. McMaster researchers find potential for new uses of old drug
3. Army researcher develops potential vaccine carrier
4. UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery
5. New study of NIH funding allocations suggests potential efficiency gains
6. A closer look at PARP-1 reveals potential new drug targets
7. Hybrid vaccine demonstrates potential to prevent breast cancer recurrence
8. VCU Massey Cancer Center sees potential in novel leukemia treatment
9. Misuse of over-the-counter pain medication is potential health threat
10. Mutations in JAK3 gene identified in subtype of lymphoma provide potential drug target
11. Bioinformatics experts at the CNIO explore additional coding potential hidden in the human genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 22, 2014 “Greenfield Naturals” was featured ... Report , which features the latest and coolest technology ... and reporter for NewsWatch, conducted the product review and ... flavor of your water. , From pollution to hazardous ... that everything is done to remove these chemicals, especially ...
(Date:11/22/2014)... (HealthDay News) -- Many young people consider hookahs a ... study finds fumes from the water pipes contain the ... increased risk for leukemia in prior research, according to ... Cancer Epidemiology, Biomarkers & Prevention . "In ... not a safe alternative to smoking other forms of ...
(Date:11/22/2014)... HealthDay Reporter FRIDAY, Nov. 21, ... homes may commonly deal with aggressive or inappropriate behavior from ... 10 centers in New York state found that, in the ... were involved in some type of incident with a fellow ... someone yelling or cursing at another resident. In other cases, ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Seeking to make it ... Food and Drug Administration on Thursday approved a new ... Hydrocodone -- best known by the brand name Vicodin ... tied to a surge in dangerous addictions across the ... Hysingla ER (hydrocodone bitartrate) is an extended-release tablet to ...
(Date:11/21/2014)... November 21, 2014 Richard Wolfe, ... , will present advanced benefits administration strategies during ... Houston HR Leadership Summit. This Game Changer breakout ... industry to present cutting-edge solutions and best practices ... explain how real-time data exchange between health and ...
Breaking Medicine News(10 mins):Health News:An Easy Home Solution to Get Better Tasting Water was Featured on NewsWatch Television on October 30, 2014 2Health News:Hookahs Deliver Toxic Benzene in Every Puff, Study Shows 2Health News:Senior-to-Senior Aggression Common in U.S. Nursing Homes 2Health News:Senior-to-Senior Aggression Common in U.S. Nursing Homes 3Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3
... difference between upbeat, less positive patients , , MONDAY, Oct. ... states predict how long a person with cancer will ... researchers say that among head and neck cancer patients, ... an independent factor affecting prognosis. , "We anticipated finding ...
... 2007; Company Prepares for ... Integration of Organon BioSciences, KENILWORTH, N.J., Oct. ... results for the third,quarter of 2007 and commented on its ... human health business,and Intervet animal health business. "Schering-Plough has ...
... Leading Employers Adopts InterviewDirect to ... Customer Support Positions, CHERRY HILL, N.J., ... provider of telephone-based job candidate screening solutions,today ... has selected,its InterviewDirect service to pre-qualify job ...
... (Oct. 22, 2007)Work done in part by researchers ... has led to the discovery of two genes that ... The findings are published in the Oct. 21 ... research on the genetic basis for common and complex ...
... bay, experts say , , SUNDAY, Oct. 21 (HealthDay News) -- ... a treat for both children and adults, according to experts ... Chicago. , "We can keep Halloween safe for everyone by ... senior vice president, said in a prepared statement. "Our vision ...
... new pledges of,commitment to invest in women,s ... and non-governmental organizations,today at closing sessions of ... mobilize political will and investment to reduce,pregnancy-related ... 1,800 participants from 109 countries cheered a ...
Cached Medicine News:Health News:Emotional State Doesn't Affect Cancer Survival 2Health News:Emotional State Doesn't Affect Cancer Survival 3Health News:Emotional State Doesn't Affect Cancer Survival 4Health News:Emotional State Doesn't Affect Cancer Survival 5Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 2Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 3Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 4Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 5Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 6Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 7Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 8Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 9Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 10Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 11Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 12Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 13Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 14Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 15Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 16Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 17Health News:Schering-Plough Reports Financial Results for Third Quarter of 2007 18Health News:Albert Einstein Healthcare Network Turns to InterviewDirect to Qualify Job Candidates 2Health News:Albert Einstein Healthcare Network Turns to InterviewDirect to Qualify Job Candidates 3Health News:UT rheumatologists discover 2 genes related to disabling form of arthritis 2Health News:UT rheumatologists discover 2 genes related to disabling form of arthritis 3Health News:Eye on Safety Makes Halloween Less Scary 2Health News:Women Deliver Conference Launches New Commitments 2
(Date:11/22/2014)... 21, 2014 Many power shifts are ... influence of patients in the biopharmaceutical market is ... more than ever, understanding how to effectively acquire, ... is essential. According to recent ... companies spent about two-thirds of their patient-focused dollars ...
(Date:11/21/2014)... , Nov. 21, 2014  The University of Maryland,s ... the ceremonial groundbreaking of the new A. James Clark ... new building will cultivate transformative new engineering and biomedical ... Taking place at 10:00 a.m. on November 21 at ... Branch Parking Lot, adjacent to the Jeong H. Kim ...
(Date:11/21/2014)...  Tandem Diabetes Care ® , Inc. (NASDAQ: ... and manufacturer of the t:slim ® Insulin ... non-profit dedicated to improving diabetes therapy management by ... diabetes data accessibility. This partnership will enable users ... development, to download and access data from their ...
Breaking Medicine Technology:New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3
...  Paragon Bioservices, Inc., a Baltimore-based CMO focused on ... today that it has been awarded a JVAP-CBMS ... the vaccine development and subsequent GMP manufacturing of ... The initial phase of the contract is ...
... Jan. 17, 2012 Roka Bioscience announced today that ... Performance Tested Method(SM) certification from the AOAC Research ... by Silliker, Inc., as part of the AOAC-RI independent ... Roka Listeria Detection Assay runs on the Atlas™ System, ...
Cached Medicine Technology:Paragon Bioservices Awarded Multi-Million Dollar DoD Contract for Filovirus Vaccine Development and Manufacturing 2Roka Bioscience Awarded AOAC-RI Certification for Roka Listeria Detection Assay 2
... The BOOKWALTER Retractor System represents ... retractor design available. Its wide array ... surgical specialites with a versatile system ... field.,Assembly is easy and uncomplicated, and ...
... ART Aerosol Resistant Tips offer a safe ... Tips are designed for applications such as ... In addition, ART Tips are excellent for ... forensic studies. ART Tips prevent aerosol contaminants ...
... disposable pipette tips, TowerPacks are ... Each Sterilized TowerPack is individually ... to help protect tips from ... the red sticker, which indicates ...
... wide orifice tip, the Finntip Wide is ... and macromolecules like genomic DNA. This tip ... fragmentation. It is excellent for use with ... the inside diameter of the orifice is ...
Medicine Products: